Ananda Basu, M.D., and researchers recently studied the difference in post-prandial glucose turnover between adolescents and adults with Type 1 diabetes (T1D).

UAB Comprehensive Diabetes Center (UCDC) Director Anath Shalev, M.D., recently presented at the prestigious 2024 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium (Levine-Riggs Symposium), held in Pasadena, CA, which is organized by City of Hope^®, one of the leading research centers for diabetes and other life-threatening illnesses.

Sasanka Ramanadham, Ph.D., and researchers published “Selective Reduction of Ca2+-Independent Phospholipase A2β (iPLA2β)-Derived Lipid Signaling from Macrophages Mitigates Type 1 Diabetes Development"in the peer-reviewed journal Diabetes.

UAB Comprehensive Diabetes Center (UCDC) Director Anath Shalev, M.D., has secured a $3 million National Institutes of Health (NIH) multi-PI R01 grant to study the effectiveness of TIX100, originally developed as an antidiabetic, in treating MASLD and MASH.

Many with Type 1 diabetes (T1D) know that exercising can be a bit tricky for the management of glucose. For instance, some types of physical activity might cause blood glucose to drop while engaging in other types of physical activity might not, and it can be difficult to anticipate blood glucose trends during exercise.

Fernando Bril, M.D., and colleagues recently investigated the relationship between insulin resistance and metabolic dysfunction-associated steatotic liver disease (MASLD). 

Haifa "Saba" Alsharif, a fifth-year graduate student in Dr. Sushant Bhatnagar's Lab, was awarded a UAB Graduate Biomedical Sciences (GBS) award for mentorship at the 2024 symposium.

Fernando Ovalle, M.D., director of the UAB Division of Endocrinology, Diabetes, and Metabolism, and associate director of the UAB Comprehensive Diabetes Center (UCDC) recently published findings comparing insulin options for Type 1 diabetes (T1D) patients.

Sushant Bhatnagar, Ph.D., associate professor in the Division of Endocrinology, Diabetes, and Metabolism and scientist in the UAB Comprehensive Diabetes Center (UCDC) received pilot funding for his project “The role of brain angiogenesis inhibitor-3 GPCR signaling in adipose tissues.”

U.S. News & World Report (USNWR) recently ranked UAB Hospital as the best hospital in Alabama, naming several of its specialties as top-ranking in the nation. UAB Hospital’s diabetes and endocrinology specialty was ranked as high performing, the highest classification.

Ambika Ashraf, M.D., division director of UAB Pediatric Endocrinology and Ralph Frohsin Endowed Chair in Pediatric Endocrinology, has delved into the intricate world of the gut microbiota (GM) and its profound impact on obesity, metabolic syndrome (MS), and Type 2 diabetes (T2D).

Tanya Pierre, a fourth-year graduate student in the lab of Chad Hunter, Ph.D., was featued in the July issue of the Endocrine Society's magazine Endocrine News.  The article,"Sweet Homeostasis Alabama: Q&A with Tanya Pierre" highlights her research and National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship (F31).

The UAB Comprehensive Diabetes Center (UCDC) is pleased to welcome Hui-Ying Lim, Ph.D., who will serve as an associate professor in the Department of Genetics.

UAB Comprehensive Diabetes Center (UCDC) Associate Director W. Timothy Garvey, M.D., and collaborators recently shared their findings from a cross-sectional online survey of 785 health care professionals (HCPs).

UAB Comprehensive Diabetes Center (UCDC) Associate Director Ambika Ashraf, M.D., published the review “Altered lipid metabolism and the development of metabolic-associated fatty liver disease” in the journal Current Opinion in Lipidology.

The American Association of Clinical Endocrinology (AACE) awarded UAB Comprehensive Diabetes Center Member and Division of Endocrinology, Diabetes, and Metabolism Professor Monica Argawal, M.D., the  Jack Baskin, MD, Endocrine Teaching Award.